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INTRODUCTION
Erythrocyte dehydration is a characteristic feature of several hematological disorders, including sickle cell anemia, ß thalassemia, and hereditary spherocytosis (HS).
1-4 K-Cl cotransport and/or Ca-activated K channel (Gardos channel, KCNN4) 5 mediate erythrocyte dehydration in sickle cell disease and ß thalassemia 6 but their role in HS is less defined.
The dehydration observed in erythrocytes of patients with HS is due to a decreased K content, which is only partially offset by an increase in cell Na. Several studies have
shown that the erythrocyte "permeability" to Na and K is increased in HS, and that the increased Na permeability is associated with increased activity of the Na-K ATPase. [7] [8] [9] [10] [11] [12] The associated increase in ATP consumption has been postulated to lead to ATP depletion during erythrostasis, followed by increased Ca entry, activation of the Gardos channel and dehydration. 8, 13 A more recent study found no changes in the transport activity of Na-K-2Cl cotransport and Na/Li exchange in human HS erythrocytes, while the Na-K pump activity was increased and the K-Cl cotransport activity decreased. 14 Thus, there are no clearly defined molecular mechanisms, which explain the increased cell Na and decreased cell K of HS erythrocytes. There is no clear link between the ion transport abnormalities of HS erythrocytes and their reduced in vivo survival; however, it has been shown that the number of microspherocytes, [erythrocytes with low cell volume (MCV) and high cell hemoglobin concentration (CHCM)] is a reasonable good indicator of disease severity. 15 For personal use only. on . by guest www.bloodjournal.org From
The ion transport properties of spherocytic erythrocytes from mice with naturally occurring mutations leading to spectrin or ankyrin deficiency have been described. 16 These studies highlighted several similarities between the murine and the human diseases, such as the increased cell Na and reduced K content, and increased passive permeability to monovalent cations. 16 In mouse erythrocytes lacking either erythroid band 3 (AE1) protein or ß adducin dehydration and microspherocytosis were reported 17, 18 . In mouse red cells lacking 4.2 membrane protein, we described an up-regulated response of Na-K-2Cl cotransport, Na-H exchange and Na leak to hypertonic shrinkage. 19 Although these studies have highlighted the functional relation between membrane proteins and ion transport pathways, no data are actually available on the role of the Ca-activated K channel in HS erythrocytes.
In the present study, we characterize the Gardos channel activity in mouse erythrocytes devoid of protein 4.1, an important component of the red cell cytoskeleton, and establish that this pathway plays a crucial role in compensating for the reduced surface membrane area of HS erythrocytes.
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METHODS
Mice with targeted deletion of 4.1, 4.2 and ß adducin have been previously described. [18] [19] [20] Control mice (C57Bl/6J and 129/SvEv) were purchased from the Jackson Laboratory, Bar Harbor, ME.
Hematological parameters, erythrocyte cation content, Gardos channel activity and biochemical parameters:
The mouse erythrocyte and reticulocyte cellular indices were measured with the ADVIA 120 hematology analyzer (Bayer Corp., Diagnostic Division, Tarrytown, NY). The red cell density profiles were determined using phthalate esters as previously described.
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Erythrocyte sodium and potassium content were determined in fresh erythrocytes by atomic absorption spectrophotometry (AAnalyst 800, Perkin Elmer, Norwalk, CT).
Gardos channel activity was determined as 86 Rb influx into erythrocytes incubated at 2% Hct in isotonic NaCl media (145 mM NaCl, 2 mM KCl, 0.15 mM MgCl 2 , 0.1 mM ouabain, 10 mM Tris-MOPS pH 7.4 at 22°C, 10 µM bumetanide, and 10 µCi /ml 86 Rb).
Free ionic calcium was buffered between 0 and 3 mM with 1 mM EGTA or citrate buffer as described by Wolff et al. 22 and Rivera et al. 23 The extracellular Ca 2+ concentration was calculated by using the dissociation constants (Kd) for EGTA or citrate and correcting for ionic strength at pH 7.4 and 0.15 mM MgCl 2 . At time 0 min, the Ca 2+ ionophore A23187 (5 µM) was added; aliquots were removed at 2 and 5 min and immediately spun down through 0.8 µL of cold media containing 5 mM EGTA buffer and an underlying cushion of n-butyl phthalate. Supernatants were aspirated and the tube tip containing the cell pellet was cut off. The erythrocyte-associated radioactivity was counted in a gamma counter (model 41600 HE, Isomedic ICN Biomedicals Inc., Costa Mesa, CA). K + uptake was linear up to 5 min and fluxes were calculated from linear regression slopes LDH, total bilirubin and plasma hemoglobin were measured on a Hitachi 917
analyzer.
In vivo studies:
Effects of CLT on 4.1-/-and wild-type mice: 4.1 -/-mice were divided into two groups, and either vehicle (n=7) or CLT (80 mg/kg; n=7) was administered orally by gavage twice daily. Hematological parameters were evaluated at baseline and after 11 days of therapy. All vehicle-treated mice were alive and well at the end of the treatment, while two of the CLT-treated animals died before day 11 (day 4 and 8). An additional group of 4.1 -/-mice was treated with higher dosages of CLT (160 mg/kg; n=7) administered orally by gavage twice daily. Hematological parameters were evaluated at baseline and after 48 hours of therapy. Only four animals were alive at the end of this treatment.
Wild-type mice (C57B6/2J) were treated with CLT (80 mg/kg; n=6) administered orally by gavage twice daily. Hematological parameters were evaluated at baseline and after 10 days of therapy. All wild-type mice were alive and well at the end of the treatment.
Effects of o-Chlorophenyl-diphenyl Acetamide on 4.1-/-mice: CLT in vivo is
metabolized into four major metabolites: diphenylmethanol, diphenylmethane, 4-xydroxyphenyl phenyl-methane and 4-xydroxyphenyl phenyl-methanol. 24 We have Hematological parameters were evaluated at baseline and after 6 days of therapy. All six animals were alive at the end of this treatment. Two band 3+/-animals were treated with high dosages of CLT (160 mg/kg) administered orally by gavage twice daily for seven days. Hematological parameters were evaluated at baseline and after 7 days of therapy. Both these animals were alive at the end of this treatment.
Measurement of erythrocyte in vivo survival:
Mouse erythrocytes were labeled with NHS-biotin. (E-Z link, Pierce; 30-40 mg/kg of body weight, administered IV) The percentage of labeled cells in peripheral blood was quantified with flow cytometry using Streptavidin R-PE. 25, 26 Histology, electron microscopy and tissue iron content studies:
Mouse tissues (spleen and liver) were fixed in phosphate-buffered formaldehyde (3.7%) prior to dehydration and paraffin embedding using standard techniques. Sections were cut at 4 µm and stained with hematoxylin and eosin or Perl's iron stain.
For
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For electron microscopy studies, washed erythrocytes were suspended in 2.5% glutaraldehyde (in Na-cacodylate buffer, pH 7.4), treated with 1% osmium tetraoxide solution, and embedded in Epon resin. Thin sections were stained with uranyl acetate and lead citrate for transmission electron microscopy.
Statistical analysis:
All values are presented as mean ± standard deviation (SD). For each group of mice, the statistical significance of changes in the variables measured after treatment was assessed by one-way analysis of variance (ANOVA) with Tukey's test for post hoc comparison of the mean.
RESULTS

Characterization of 4.1-/-erythrocytes: ion content and osmotic fragility.
4.1 -/-erythrocytes exhibit a marked increase in cell Na and a marked decrease in cell K and total cation content compared to wild-type mice (Table 1) . Cell dehydration is evident both from the increased CHCM (Table 1) , and from the right-shifted phthalate density profile (Fig. 1) . (Table 1) .
Osmotic fragility is increased in 4.1 -/-erythrocytes: compared with mouse strains deficient in other cytoskeletal proteins (4.2 and ß adducin) 4.1 -/-erythrocytes show a more pronounced shift toward higher densities and greater osmotic fragility (Fig. 1) .
In vitro functional characterization of the Gardos channel activity of 4.1 -/-erythrocytes:
The dependence on extracellular Ca 2+ of K transport via the Gardos channel was studied in control and 4.1 -/-erythrocytes. 23 In control erythrocytes, charybdotoxin (ChTX)-sensitive K influx increased rapidly and saturated around 5.8 mmol/L cell x min, when ionized Ca 2+ was increased up to 3 µM (Fig. 2) .
FIGURE 2
For personal use only. on . by guest www.bloodjournal.org From Nonlinear fitting of the experimental points for a hyperbolic function gave a V max of 6.08 ± 0.09 mmol/L cell x min (n=4). ChTX-sensitive flux kinetic analysis showed a constant affinity for Ca 2+ (K m ) of 1.47 ± 0.02 µM. In 4.1 -/-erythrocytes, similar kinetic analysis revealed the V max of the system to be significantly higher (from 6.08 to 9.75 ± 1.06 mmol/L cell x min, n=3, p<0.04) and the affinity constant for Ca 2+ to be significantly lower (from 1.47 to 1.01 ± 0.06 µM, n=3, p<0.03) than in control erythrocytes (Fig. 2) . Thus, in 4.1 -/-erythrocytes, the activation of the Gardos channel occurs at a much lower intracellular Ca 2+ concentration than in control erythrocytes.
Effects of in vivo Gardos channel inhibition on erythrocytes of 4.1 -/-mice:
Effects of CLT treatment on 4.1-/-mouse erythrocytes:
To determine the in vivo role of the Gardos channel in murine HS, 4.1 -/-mice were treated with oral CLT, a powerful Gardos channel blocker, at dosages of 80 mg/Kg/BID for 11 days. 27 While previous studies with CLT in normal or SAD mice had been associated with no mortality, 2 of the 7 treated animals died at day 4 and 8 of treatment. No deaths were observed in a group of 7 vehicletreated 4.1 -/-mice. In the 5 surviving mice, 11 days of CLT treatment were associated with a significant increase in erythrocyte dehydration, assessed by the % of cells with CHCM > 37 g/dl (Table 2 , Fig. 3 ). (Table 2 ) and the % of immature reticulocytes (from 19.5±1.8 to 28.2±8.0%) were noted, suggesting worsening of anemia/hemolysis and cell dehydration. Cell Na content was significantly increased after CLT treatment, while no changes were evident in red cell K content, most likely because the increase in dense dehydrated cells with lower K content was offset by the increase in reticulocytes which have higher K content (data not shown). Thus, blockade of the Gardos channel in vivo results in a paradoxical worsening of dehydration and marked enhancement of the formation of microspherocytes. A similar treatment schema carried out in 7 normal control C57BL/6 mice at 80 mg CLT/Kg BID for ten days showed no mortality/morbidity and no changes in erythrocyte or reticulocyte parameters (Fig. 3) .
To assess if these changes could be produced at shorter time intervals, seven 4.1 -/-mice were treated with 160 mg CLT/kg/BID for 48 hrs. Such a treatment in previous studies had also been well tolerated with no toxicities or deaths. 27 Three animals died before the completion of the treatment. High dose CLT treatment of 4.1 -/-mice resulted in significant reductions in Hb Hct, and increases in HDW percent of hyperchromic erythrocytes and cell Na. Plasma Hb, LDH, and bilirubin levels increased significantly with CLT administration (Table   3 ). To demonstrate that CLT administration was associated with worsening of hemolysis, erythrocyte survival was measured in 4.1 -/-animals treated with 80 mg/Kg/BID of CLT for 11 days. Compared with untreated 4.1 -/-animals ( Fig. 4) , CLT treatment resulted in a shortened survival of erythrocytes.
Changes in plasma levels of LDH, bilirubin, and hemoglobin were also indicative of an increased hemolysis in 4.1 -/-mice treated with CLT (Table 3) . Since CLT has several additional pharmacological effects which are not due to Gardos channel inhibition, but rather to the imidazole moiety of CLT and its cytochrome P 450 inhibitor effect, 28, 29 it was important to determine whether the effects seen in 4.1 -/-mice indeed resulted from blockade of the Gardos channel. Therefore, we treated six 4.1 -/-mice with a member of a new class of compounds which have no imidazole moiety, and have greater in vitro inhibitory potency than CLT on the Gardos channel. 30 The compound, o-Chlorophenyl-diphenyl acetamide, inhibits the Gardos channel in vitro with an IC 50 value of 5 nM compared with the CLT IC 50 of 60 nM (Brugnara C, unpublished data). This compound is different from that currently being tested in patients with sickle cell disease, 31 and has never been previously used in mice: no data are thus available on its oral bioavailability and pharmacokinetic. Two animals did not survive the treatment and four remaining animals were studied after 7 days of treatment at dosages of 100 mg/Kg/BID. We noted significant reductions in Hct, Hb, and increases in CHCM, in the % of hyperchromic erythrocytes, in the % of hyperchromic microcytes, cell Na and indicators of hemolysis (Fig. 3 , Table 2 
and 3).
To evaluate if the effects seen in 4.1 -/-mice could also be seen in other mouse models of HS, six 4.2 -/-animals were treated for 6 days with CLT at dosages of 160 mg/kg/BID. CLT administration resulted in significant increase in HDW, in the % of hyperchromic erythrocytes and in cell Na, again indicating that CLT administration resulted in an increased formation of dense, dehydrated erythrocytes ( Table 2 , Fig. 3 ).
Since no mice with complete deficiency in erythrocyte band 3 were available for this study, two mice heterozygous for band 3 deficiency (band 3 +/-) were studied with CLT at dosages of 160 mg/Kg/BID for 48 hours. As in the other mouse strains, band 3 +/-animals showed increased cell dehydration and increased cell Na content with CLT administration (Fig. 3) .
Effects of CLT treatment on liver-spleen and kidney histopathology:
Routine histological analysis of necropsied animals demonstrated no distinctive features between the drug-treated and untreated animals in the liver or spleen, both in terms of H&E morphology or the extent or pattern of distribution of iron staining. By contrast, the kidneys of CLT-treated animals
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consistently showed a decreased intensity of renal tubular epithelial iron staining; the staining also tended to terminate in more proximal portions of the renal tubules in the drug treated group ( Figure   5 ). Since our data indicated that intravascular hemolysis was increased by CLT treatment, it is possible that these changes in tissue iron deposition may be due a decreased renal tubular reabsorption of iron in drug-treated animals.
FIGURE 5
DISCUSSION
We have shown in this report that the Gardos channel plays an important role in modulating erythrocyte ion content and hydration state in murine spherocytosis. In vitro studies showed that this channel is functionally up-regulated in 4.1 -/-erythrocytes conferring to 4.1 -/-erythrocytes an increased tendency to lose K when exposed to conditions resulting in increased intracellular Ca levels. It remains to be established if this functional up-regulation is specific for 4.1-/-erythrocytes or is a general property of all murine spherocytosis. In vivo experiments were carried out by using specific blockers of the Gardos channel, to assess the consequences of a functional blockade of this pathway. Rather than producing cell swelling and an increase in K content (as we observed in sickle mice treated with CLT), 27 CLT treatment worsened erythrocyte dehydration, and increased the number of microspherocytes, suggesting that K loss via this channel is crucial in preventing hemolysis when, as a consequence of cytoskeletal instability, membrane surface area is lost.
Blockade of the Gardos channel by CLT was associated with signs of increased hemolysis such as increased LDH, bilirubin, plasma Hb, and reticulocyte counts, and reduced red cell lifespan. Effects essentially similar to those of CLT were obtained with o-Chlorophenyl-diphenyl Acetamide, a Gardos channel inhibitor devoid of the imidazole moiety, which is responsible for cytochrome P 450 inhibition.
Therefore, these findings cannot be merely explained by CLT influencing microvesiculation, which Gardos channel activity in red cells of patients with myopathy and hemolytic anemia due to inherited phosphofructokinase (PFK) deficiency. 34 In vitro normal red cells exposed to oxidants or to synthetic prostaglandins (PGE-2) showed abnormal activation of the Gardos channel, resulting in red cell dehydration. are too large to be filtered through the kidney glomerulus. These effects will need to be further investigated.
In conclusion, 4.1 -/-erythrocytes exhibit dehydrated red cells, reduced red cell K content and abnormal Gardos channel activation. In vivo blockade of the Gardos channel is associated with worsening anemia, hemolysis and erythrocyte fragmentation, indicating that this pathway may play an important role in protecting spherocytic erythrocytes from reaching their critical hemolytic volume.
Importantly, the reported findings imply that K and water loss via the Gardos channel may play an important protective role in compensating for the reduced surface membrane area of all forms of HS erythrocytes with various cytoskeletal impairments and thereby reducing hemolysis. For personal use only. on . by guest www.bloodjournal.org From
